Selected presentations from the 1st Congress on Controversies in
Thrombosis and Hemostasis (CiTH) 30 October - November 1, 2014, Berlin, Germany
Patients with Factor VII or Factor XI deficiency: do they need treatment prior to surgery?
P. Bolton-Maggs, UK
|
 |
Hemophiliacare: Currentguidelinesandapplicationsof new factor concentrates
K. Fischer, Netherlands
|
 |
NOACS for the treatment of atrial fibrillation - advantages
E. Lev, Israel
|
 |
New Antiplatelet Agents - Advantages
E. Lev, Israel
|
 |
Antiphospholipid syndrome in children - should similar diagnostic criteria be applied?
V. Pengo, Italy
|
 |
Bleeding Associated with NOACs: Assesing the Risk and Management
D. Varon, Israel
|
 |
Should infants with perinatal thrombosis be screened for thrombophilia and treated by anticoagulants?
S. Revel-Vilk, Israel
|
 |
Should we screen children for coagulopathies prior to surgery?
S. Revel-Vilk, Israel
|
 |
New Antiplatelet Agents: Limitations
A. Michelson, USA
|
 |
New Oral Anticoagulants in Children: Should They Be Prescribed For Special (Off Label) Situation? No
A. Michelson, USA
|
 |
The role of thrombopoietics in ITP
J. Bussel, USA
|
 |
Hemostasis and liver disease
P. Mannucci, Italy
|
 |